-+ 0.00%
-+ 0.00%
-+ 0.00%

*Aprea Therapeutics Expects Proceeds From Offering to Be Sufficient to Extend Cash Runway Into 1Q 2028, in Each Case, Based on Current Business Plans, Assumptions >APRE

Dow Jones·03/30/2026 12:14:00

Please log in to view news